Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Brimonidine tartrate

Brimonidine tartrate is an alph -adrenergic receptor agonist used to lower IOP in patients with open-angle glaucoma or ocular hypertension. This drug acts to reduce aqueous humor production and increase the outflow of aqueous humor. [Pg.620]

Although side effects are usually mild, treatment with brimonidine tartrate includes oral dryness, ocular hyperemia, burning and stinging, headache, visual blurring, foreign body sensation, fatigue drowsiness, ovular allergic reactions, and ocular pruritus. [Pg.626]

The recommended dose is 1 drop of brimonidine tartrate in the affected eye(s) 3... [Pg.2074]

Hypersensitivity to brimonidine tartrate or any component of this medication patients receiving monoamine oxidase inhibitor (MAOl) therapy. [Pg.2075]

Brimonidine tartrate Alpha 2-adrenoreceptor agonist, adjunct in glaucoma... [Pg.459]

Sympathomimetic agents, such as brimonidine tartrate, apraclonidine, adrenaline and dipivefrine hydrochloride, which is a prodrug for adrenaline), act on a-adrenoreceptors to induce dilation of the veins to reduce IOP. They also induce mydriasis (dilation of the pupils). Adrenaline may reduce the rate of formation of the aqueous humour, which in turn reduces the IOP it may also increase the outflow through the trabecular meshwork. Stimulation of alpha-2-adrenoreceptor (c -adrenoreceptor) by drugs such as brimonidine and apraclonidine on the adrenergic neurons supplying the ciliary body can also result in reduction of secretion of aqueous humour. [Pg.291]

Aim A, Berggren L, Hartvig p Roosdorp M. Monitoring acetazo-lamide treatment.Acta Ophthalmol 1982 60 24-34. Al-Shahwan S,Al-Torbak AA,Turkmani S, et al. Side-effect profQe of brimonidine tartrate in children. Ophthalmology 2005 112 2143-2148. [Pg.170]

Katz LJ. Brimonidine tartrate 0.2% twice daily vs. timolol 0.5% twice daily 1-year results in glaucoma patients. Brimonidine Study Group.Am J Ophthalmol 1999 127 20-26. [Pg.172]

Thordsen JE, Bower KS, Warren BB, et al. Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes.J Cataract Refract Surg 2004 30 1702-1706. [Pg.173]

Figure 10-11 Effect of brimonidine 0.2% and timolol 0.5% at peak 2 hours after morning drug instillation. Asterisks indicate statistically lower intraocular pressure with brimonidine at week 1, week 2, month 3, and month 12. (Adapted from Katz LJ. Brimomdine tartrate 0.2% twice daily versus timolol 0.5% twice daily 1-year results in glaucoma patients.Am J Ophthalmol 1999 127 20-26.)... Figure 10-11 Effect of brimonidine 0.2% and timolol 0.5% at peak 2 hours after morning drug instillation. Asterisks indicate statistically lower intraocular pressure with brimonidine at week 1, week 2, month 3, and month 12. (Adapted from Katz LJ. Brimomdine tartrate 0.2% twice daily versus timolol 0.5% twice daily 1-year results in glaucoma patients.Am J Ophthalmol 1999 127 20-26.)...
See other pages where Brimonidine tartrate is mentioned: [Pg.406]    [Pg.2074]    [Pg.471]    [Pg.586]    [Pg.155]    [Pg.191]    [Pg.1739]    [Pg.55]    [Pg.111]    [Pg.111]    [Pg.406]    [Pg.2074]    [Pg.471]    [Pg.586]    [Pg.155]    [Pg.191]    [Pg.1739]    [Pg.55]    [Pg.111]    [Pg.111]   
See also in sourсe #XX -- [ Pg.152 ]

See also in sourсe #XX -- [ Pg.111 ]



SEARCH



Tartrate

© 2024 chempedia.info